Impact Factor
4.82
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
23.46
5,709 total citations
h5-index
94
h5 depth signal
Cited share
94.1%
240 of 255
Total citations
5,709
Citation footprint
Metric signal
25.06
External metric anchor
Self-citation
3.3%
190 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
329
China
293
Germany
112
United Kingdom
109
Netherlands
102
Citing Fields of Research
Noncoding RNA
881
Cell Biology
197
Immunology
173
Stem Cell Biology
119
Cancer & Development
66
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,290
Articles tracked across the journal lifetime
Indexed publication set
255
240 cited publications
Last 12 months
210
17.5 publications/month
Open access share
99.0%
208 OA publications in the last year
Leading citing country
United States
329 citing publications
Leading citing field
Noncoding RNA
881 citing publications
Latest tracked publication
10 October 2026
10 recent records available
Coverage & Indexing History
v10n1, Nov. 2020-
v1, 2012-
Active Coverage
Research Focus & Classification
Indexed Subjects
Noncoding RNA
Issuing & Sponsoring Bodies
Contributor
International Society for Extracellular Vesicles
Broad Categories
Biomedical Engineering
Cell Biology
Noncoding RNA
MeSH Descriptors
Transport Vesicles
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1002/jev2.70372
Open DOI
Tissue‐Specific Isolation of Hepatocyte Extracellular Vesicles From Human Plasma Enables Tissue‐Resolved Proteomic and miRNA Profiling
Tissue‐specific resolution remains a critical barrier in liquid biopsy for precision medicine. To address this, we developed NEXPLOR (Novel EXtracellular vesicle PopuLation Omics Revealer), an immunoaffinity platform enabling selective e...
02
DOI 10.1002/jev2.70386
Open DOI
M2 Macrophage‐Derived Small Extracellular Vesicle miR‐106a‐Loaded QCG Hydrogel Targets the RNF128‐LXR Pathway to Reprogram Chondrocyte Cholesterol Metabolism for Osteoarthritis Therapy
This study addresses osteoarthritis (OA), in which dysregulated chondrocyte cholesterol homeostasis and cellular senescence contribute to cartilage degeneration, by developing an inflammation‐responsive injectable QCG hydrogel for local ...
03
DOI 10.1002/jev2.70382
Open DOI
Heparin Can Augment Extracellular Vesicle Yield by Inhibiting Reuptake in Donor Cells During Cell Propagation
Extracellular vesicles (EVs) mediate cell‐to‐cell communication in development, health and disease. Heparin is a common component in human induced pluripotent stem cell (hiPSC) media but its impact on hiPSC‐EVs beyond stabilizing growth ...
04
DOI 10.1002/jev2.70371
Open DOI
Agrin‐Enriched Neonatal Spinal Cord‐Derived Extracellular Vesicles Bypass Age Barriers to Organize Spinal Cord Repair
Spinal cord injury (SCI) poses a formidable challenge in regenerative medicine, with current therapeutic strategies proving largely unsuccessful in achieving functional repair. Notably, paediatric patients and neonatal mice exhibit spont...
05
DOI 10.1002/jev2.70383
Open DOI
MVB Maturation Responsive to KRAS G12D /TP53 R175H Co‐mutations Fuels Extracellular Vesicle‐hypersecretion Phenotype to Aggravate Lymphangiogenesis and Lymphatic Metastasis
KRAS
G12D
/TP53
R175H
mutations are hallmarks of malignant tumor progression and are associated with lymph node (LN) metastasis in solid tumor. Nevertheless, the mechanisms underlying KRAS
G12D
/TP53
R175H
co‐mutation‐mediated LN...
06
DOI 10.1002/jev2.70364
Open DOI
Longitudinally Monitoring Prostate Cancer Bone Metastasis and Treatment Response via Circulating Extracellular Vesicles
Lethal prostate cancer (PCa) is dominated by treatment‐refractory progression in bone. In this study, we used plasma‐derived extracellular vesicles (EVs) for monitoring the tumour and therapy‐induced changes in the bone tumour microenvir...
07
DOI 10.1002/jev2.70377
Open DOI
C1qc Mediates Blood–Brain Barrier Disruption in a Mouse Model of Intracerebral Haemorrhage Through Microglia‐Derived Migrasomes
Extracellular vesicles (EVs) are essential for intercellular communication and significantly influence neuroimmune responses after intracerebral haemorrhage (ICH). This study elucidates the immune mechanisms underlying secondary brain in...
08
DOI 10.1002/jev2.70373
Open DOI
Bacterial Cytochrome C Orchestrates Larval Metamorphosis Through Bioelectrical Control of Extracellular Vesicles Biogenesis
Beyond the well‐established roles in biomedical processes, extracellular vesicles (EVs) from Gram‐negative bacteria are now identified as potent inducers of larval metamorphosis in marine invertebrates, a critical process for sustaining ...
09
DOI 10.1002/jev2.70379
Open DOI
Dual‐Targeted M1 Macrophage Extracellular Vesicles Reprogram the Tumor Microenvironment and Enhance Natural Killer Cell Immunotherapy in Breast Cancer
Breast cancer is the most commonly diagnosed cancer worldwide and a leading cause of cancer‐related mortality in women. Despite therapeutic advances, treating advanced or recurrent cases is substantially hampered by drug resistance and t...
10
DOI 10.1002/jev2.70387
Open DOI
Extracellular Vesicle‐Bound Bacterial Toxin Pneumolysin Triggers Membrane Engagement and Damage Beyond Canonical Pore Formation
Pneumolysin (PLY) is a cholesterol‐dependent pore‐forming toxin and a key virulence factor of Streptococcus pneumoniae , the leading cause of pneumonia worldwide in children aged below 5 years. At sublytic toxin doses, host cells shed PL...
Bibliographical & Catalog Notes
Includes supplements.